Ganciclovir

   
Google
 
Web NewDrugInformation.com

Ganciclovir


Drug - Ganciclovir
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ganciclovir
Multiple ingredients are in alphabetical order.

Strength - 250MG
The potency of the active ingredient(s), Ganciclovir. May repeat for multiple part products.

Applicant - RANBAXY
The firm name holding legal responsibility for Ganciclovir. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076457
The FDA assigned number to Ganciclovir. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Ganciclovir. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 27, 2003
The date Ganciclovir was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Ganciclovir. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Ganciclovir is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ranbaxy Laboratories Ltd
The full name of the firm holding legal responsibility for the new application of Ganciclovir.

Ganciclovir